Neurology
Starting from
$5,000
Up to $30,000 depending on centre
Typical duration
10–30 days
Including pre-operative work-up
Partner hospitals
1
Vetted for outcome data & accreditation
Content reviewed for medical accuracy by: Dr. Rodina Ainasoa · Medical Content Writer & Health Communications
Receive expert neurological assessment and access to the latest disease-modifying therapies (DMTs), infusion treatments, and specialist care for multiple sclerosis, Parkinson's disease, and other movement disorders. Leading neurology centers in India and Israel offer internationally accredited MS clinics and movement disorder programs at significantly reduced costs.
Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.
Multiple Sclerosis & Movement Disorder Treatment
Coordinated from
or message us on WhatsApp
No commitment required. Your data is never shared with third parties.
Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.
| Country | Avg. cost | vs. cheapest |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $6,000 | —chevron_right |
🇹🇷 Turkey Istanbul | $18,750 | +213%chevron_right |
Costs are indicative estimates and vary by procedure specifics, hospital, and clinical complexity. Request a personalised estimate for your specific case.
This treatment category covers several different operations with different levels of invasiveness, recovery times, and costs. The country averages above blend all of them together — use the breakdown below for a more realistic, procedure-specific estimate.
An ongoing medication — given as an infusion, injection, or daily tablet depending on the drug — that reduces relapse frequency and slows new nerve damage in relapsing forms of MS. This is a long-term repeat therapy, not a one-time procedure, and the specific drug is chosen based on disease activity, prior treatment response, and safety monitoring needs.
Typical recovery · Ongoing therapy
Infusion DMTs (e.g. natalizumab, ocrelizumab) are typically given every 4–6 months as an outpatient visit lasting a few hours, with brief monitoring afterward; oral and injectable DMTs are self-administered daily or weekly at home. There is no surgical recovery — treatment continues indefinitely under neurologist supervision, with periodic MRI and blood monitoring for safety.
India
$3,000–$8,000 per year
Turkey
$4,000–$10,000 per year
Thailand
Estimate pending verification — ask your care coordinator for a current quote
The patient's own blood-forming stem cells are collected, the immune system is then largely wiped out with high-dose chemotherapy, and the stored stem cells are reinfused to rebuild a new, less inflammatory immune system. This is a serious, higher-risk intervention typically reserved for younger patients with aggressive, actively inflammatory relapsing MS who have failed standard DMTs — it is not a first-line or routine option, and candidacy requires careful specialist assessment.
Typical recovery · 3–4 week hospital stay
Involves stem cell collection, then 2–3 weeks of inpatient care during and after conditioning chemotherapy while blood counts recover in isolation, similar in intensity to a bone marrow transplant; patients should plan for 4–6 weeks in-country and a further several months of reduced immunity and infection precautions at home before returning to normal activity.
India
$18,000–$30,000
Turkey
$12,000–$25,000
Thailand
Estimate pending verification — ask your care coordinator for a current quote
A surgically implanted device delivers targeted electrical stimulation to specific deep-brain structures to reduce tremor, stiffness, and motor fluctuations in Parkinson's disease. This page covers it only at a general level as part of the movement-disorder category — more procedure-specific detail on candidacy, electrode placement, and programming is available on our dedicated deep brain stimulation page.
Typical recovery · 4–6 weeks
Typically a 2–4 night hospital stay for electrode and pulse-generator implantation, followed by a device activation and programming visit some weeks later; most patients resume light activity within a few weeks, with stimulation settings fine-tuned over the following months.
India
$20,000–$32,000
Turkey
$21,000–$40,000
Thailand
$27,000–$37,000
Botulinum toxin is injected directly into overactive, spastic muscles to temporarily reduce excessive muscle tone and improve comfort, positioning, or function. This is a repeat therapy, not a one-time procedure — it does not cure spasticity, and the effect wears off over time.
Typical recovery · Repeat every 3–4 months
Performed as a short outpatient visit with little to no downtime; benefit typically begins within days to two weeks, peaks by 4–6 weeks, and wears off after roughly 3–4 months, at which point the injections are repeated to maintain effect.
India
$500–$1,500 per session
Turkey
Estimate pending verification — ask your care coordinator for a current quote
Thailand
Estimate pending verification — ask your care coordinator for a current quote
Cost ranges are indicative estimates for international patients and vary with implant choice, number of levels treated, surgeon, and hospital. Request a personalised quote for your specific case.
Clinical detail: AAOS OrthoInfo, Mayo Clinic Health System, Cleveland Clinic. Cost ranges cross-checked across multiple independent medical-tourism sources per country where marked; ranges flagged "pending verification" could not be independently confirmed at the time of writing.
Faridabad, India
Asia's largest private hospital — 2,600 beds, 64 operation theatres, 81 specialties on a 130-acre campus in Delhi NCR. NABH & NABL accredited. Centres of excellence in oncology, cardiac surgery, BMT, organ transplantation, neurosciences, and IVF.
800+
Specialists
2,600+
Beds
Yes — this is one of the most common reasons MS patients seek care internationally. Countries like India and Turkey have access to approved DMTs (including natalizumab, ocrelizumab, and alemtuzumab) at 40–70% lower cost than in the US, UK, or Africa. Some treatments like HSCT for MS are also available in accredited centers in India and Turkey but remain experimental or inaccessible in many countries. Our coordinators will review your current diagnosis, MRI reports, and treatment history to match you with the most appropriate center and treatment protocol.
No fees. No commitment.
We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.
